CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians should claim only the credit commensurate with the extent of their participation in the activity. Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.
OVERVIEW
Percutaneous mitral valve repair using the MitraClip device to correct secondary mitral regurgitation (MR) was studied in both the COAPT and MITRA-FR trials. The aim was to assess the efficacy and safety of MitraClip in patients with systolic heart failure and severe secondary MR. Severe secondary MR is associated with a poor prognosis in patients with chronic heart failure and reduced left ventricular ejection fraction (LVEF). In this webcast, a panel of experts will discuss the clinical implications of the trial results, discuss the optimal patient characteristics who will benefit and the importance of including heart failure specialists and imagers to optimize patient outcomes.
LEARNING OBJECTIVES
By the end of this program, participants should be able to:
• Compare and contrast COAPT and MITRA-FR results
• Define patient characteristics and anatomic considerations that most benefit from mitral valve intervention
• Describe the role of multiparametric echo analysis to determine mitral regurgitation level
TARGET AUDIENCE
This educational activity is designed for interventional cardiologists, clinical cardiologists, and other healthcare professionals involved in the management of patients with valvular heart disease.
ACTIVITY EVALUATION
Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.
DISCLOSURE STATEMENT
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the course directors of this activity.
All Planners (Directors, Co-Directors and Chairs) and Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Anyone in noncompliance with this policy is not permitted to participate in this activity.
FACULTY DISCLOSURE SUMMARY
KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E/S/O) Equity/Stock(s)/Options (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit
Scott Lim – (G/R) Abbott Vascular; Bard Medical; Boston Scientific Corporation; Edwards Lifesciences; Medtronic; W.L. Gore & Associates; (C/H/S) Pipeline Medical; Other; (E) (R/I) 510 Kardiac
Michael Mack – Nothing to disclose
Milton Packer – Nothing to disclose
Gregg Stone – (C/H/S) Shockwave; Valfix; Reva; TherOx; Vascular Dynamics; Robocath; HeartFlow; W.L. Gore & Associates; Ablative Solutions; Miracor; Neovasc; V-wave; Abiomed; Ancora; SpectraWave; MAIA Pharmaceuticals; Orchestra Biomed; (E) Ancora; SpectraWave; Qool Therapeutics; Cagent; Applied Therapeutics; Biostar family of funds; MedFocus family of funds; Orchestra Biomed; Aria
Content Reviewer(s):
Gary S. Mintz, MD – Nothing to disclose
Joe Heard, MHA - Nothing to disclose
Colleen Whelan - Nothing to disclose
ACTIVITY SPONSORSHIP AND SUPPORT
This program is sponsored by the Cardiovascular Research Foundation and supported through an unrestricted grant from Abbott. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience. This program was developed without influence from commercial supporters.
HOW TO RECEIVE CME CREDIT
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Joe Heard at jheard@crf.org .